Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

KD Cummins, SM Jane, S Nikovic, A Bazargan, R Filshie, G Sutrave, M Hertzberg, A Scott, S Lane, CK Yannakou, D Ritchie, J D'Rozario, J Black, K Bavishi, A Wei